Product ID: SQMIG35G2238
Report ID:
SQMIG35G2238 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
147 |
Figures:
78
In 2021, North America held the largest share of the global interventional oncology market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. However, Asia-Pacific will be the fastest expanding regional market due to the region's faster economic expansion and increased government attention on the healthcare sector. Furthermore, government initiatives to develop healthcare facilities, rising cancer incidence and prevalence, rising awareness of overall health and treatment availability, increasing middle-class population and disposable income, increasing health insurance penetration, and a growing ageing population in the region are key factors driving the growth of the Asia-Pacific interventional oncology market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONInterventional Oncology Market size was valued at USD 1984 million in 2019 and is poised to grow from USD 2134.78 million in 2023 to USD 4127.28 million by 2031, growing at a CAGR of 7.6% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35G2238